BSEResultResults31 Jul 2026
SMS Pharmaceuticals Ltd
Please find the enclosure
SMS Pharmaceuticals Ltd has announced its financial results for the quarter ended 30th June, 2026, with revenue from operations at Rs. 20,696.49 lakhs and a net profit of Rs. 2,814.42 lakhs. The company has also approved the re-appointment of Mr. Ramesh Babu Potluri as Chairman and Managing Director for a term of 5 years, subject to shareholder approval. Additionally, the company has approved giving a loan to its subsidiary, SMS Peptides Private Limited, up to Rs. 50 crores.
BSEBoard MeetingResults31 Jul 2026
SMS Pharmaceuticals Ltd
Please find the enclosure
SMS Pharmaceuticals Ltd has announced its Q1 FY26 financial results, with revenue from operations at Rs. 20,696.49 lakhs and profit before tax at Rs. 2,814.42 lakhs. The company has also approved the re-appointment of its Managing Director, Mr. Ramesh Babu Potluri, for a term of 5 years. Additionally, the company has approved giving a loan to its subsidiary, SMS Peptides Private Limited, up to Rs. 50 crores.
BSECompany Update29 Jul 2026
SMS Pharmaceuticals Ltd
The Board Meeting to be held on 01/08/2026 has been revised to 31/07/2026 The Board Meeting to be held on 01/08/2026 has been revised to 31/07/2026
The Board Meeting of SMS Pharmaceuticals Ltd has been rescheduled from 1st August 2026 to 31st July 2026 due to unavoidable administrative exigencies.
BSEBoard MeetingResults25 Jul 2026
SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve Un-audited Financial Results ....
SMS Pharmaceuticals Ltd has scheduled a board meeting on August 1, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
BSECompany UpdateESG22 Jul 2026
SMS Pharmaceuticals Ltd
Copy of Newspaper Publication for information regarding transfer of shares to IEPF.
SMS Pharmaceuticals Ltd has published a newspaper advertisement informing shareholders about the transfer of shares to the Investor Education and Protection Fund (IEPF) due to unpaid/unclaimed dividend for the financial year 2018-2019.
BSECompany UpdateRegulatory22 Jul 2026
SMS Pharmaceuticals Ltd
Please find attached
SMS Pharmaceuticals Ltd has issued a reminder letter to shareholders who have not claimed their dividends for seven or more consecutive years, informing them that their shares will be transferred to the Investor Education and Protection Fund (IEPF) if they fail to claim the dividend. The company has attached a specimen of the reminder letter and has requested shareholders to claim the dividend by making an application in the attached form and sending it to the registrar and transfer agent on or before October 25, 2026.